Actinomycetes represent the microbial group richest in production of v
ariable secondary metabolites. These mostly bioactive molecules are th
e end products of complex multistep biosynthetic pathways. Recent prog
ress in the molecular genetics and biochemistry of the biosynthetic ca
pacities of actinomycetes enables first attempts to redesign these pat
hways in a directed fashion. However, in contrast to several examples
of designed biochemical improvement of primary metabolic processes in
microorganisms, none of the products or strains derived from pathway e
ngineering in actinomycetes discussed herein have reached pilot or pro
duction scale. The main reasons for this slow progress are the complic
ated pathways themselves, their complex regulation during the actinomy
cete cell cycle, and their uniqueness, as most pathways and products a
re specific for a strain rather than for a given species or larger tax
onomic group. However, the modular use of a minimum of very similar en
zymes and their conversion of similar intermediates to form the buildi
ng blocks for the production of a maximum of divergent end products gi
ves hope for the future application of these genetic models for the re
design of complex pathways for modified or new natural products. Sever
al strategies that can be followed to reach this aim are discussed, ma
inly for the variable 6-deoxyhexose metabolism as an ubiquitously appl
icable example.